Linked Data API

Show Search Form

Search Results

1670385
star this property registered interest false more like this
star this property date less than 2023-11-15more like thismore than 2023-11-15
star this property answering body
Department of Health and Social Care remove filter
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Tumours: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether NICE assessments of rare tumour type treatments consider both the failure rate of radiotherapy and the success rate of new treatments. more like this
unstar this property tabling member constituency North East Hampshire remove filter
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 2190 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer remove filter
star this property answer text <p>In its evaluations of new health technologies, including for rare diseases, the National Institute for Health and Care Excellence (NICE) takes into account all health-related costs and benefits, including evidence of comparative outcomes against existing treatment options such as radiotherapy. Full details of the process and methods used by NICE in undertaking evaluations are set out in NICE health technology evaluations: the manual, published on the NICE website and available at the following link:</p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nice.org.uk%2Fprocess%2Fpmg36%2Fchapter%2Fintroduction-to-health-technology-evaluation&amp;data=05%7C01%7CMD.Support%40dhsc.gov.uk%7C333109cf26904e79aba608dbe7825f03%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638358319347196670%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=hNltwwubSKJyLzQAyiKcpnHhf45seq1SehLv59TkbCo%3D&amp;reserved=0" target="_blank">https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation</a></p>
star this property answering member constituency Pendle more like this
unstar this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2023-11-20T16:42:51.08Zmore like thismore than 2023-11-20T16:42:51.08Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
unstar this property tabling member
4498
unstar this property label Biography information for Mr Ranil Jayawardena more like this